Heart Capital Lease Obligations from 2010 to 2024
| HSCS Stock | USD 2.90 0.04 1.40% |
Capital Lease Obligations | First Reported 2010-12-31 | Previous Quarter 536.3 K | Current Value 370.4 K | Quarterly Volatility 114.6 K |
Check Heart Test financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heart Test's main balance sheet or income statement drivers, such as Depreciation And Amortization of 58.5 K, Interest Expense of 242.9 K or Selling General Administrative of 2.5 M, as well as many indicators such as Price To Sales Ratio of 349, Dividend Yield of 0.0 or PTB Ratio of 0.42. Heart financial statements analysis is a perfect complement when working with Heart Test Valuation or Volatility modules.
Heart | Capital Lease Obligations |
Latest Heart Test's Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of Heart Test Laboratories over the last few years. Heart Test Laboratories capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Heart Test asset purchases. For example, Heart Test can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Heart Test control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Heart Test's Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heart Test's overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
Heart Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 312,109 | |
| Geometric Mean | 291,103 | |
| Coefficient Of Variation | 36.72 | |
| Mean Deviation | 71,507 | |
| Median | 291,944 | |
| Standard Deviation | 114,620 | |
| Sample Variance | 13.1B | |
| Range | 474.9K | |
| R-Value | 0.32 | |
| Mean Square Error | 12.7B | |
| R-Squared | 0.10 | |
| Significance | 0.24 | |
| Slope | 8,219 | |
| Total Sum of Squares | 183.9B |
Heart Capital Lease Obligations History
About Heart Test Financial Statements
Heart Test shareholders use historical fundamental indicators, such as Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Although Heart Test investors may analyze each financial statement separately, they are all interrelated. The changes in Heart Test's assets and liabilities, for example, are also reflected in the revenues and expenses on on Heart Test's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 536.3 K | 370.4 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.